Drug Type Autologous CAR-T |
Synonyms |
Target |
Action inhibitors |
Mechanism CLDN18.2 inhibitors(Claudin 18.2 inhibitors) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | China | 04 Aug 2022 | |
Gastroesophageal junction adenocarcinoma | Phase 1 | China | 04 Aug 2022 | |
Pancreatic Cancer | Phase 1 | China | 04 Aug 2022 | |
stomach adenocarcinoma | Phase 1 | China | 04 Aug 2022 |